Essilor® Stellest® Lenses Multicentre European Study (SLOMES)
NCT: NCT06263946 · ACTIVE_NOT_RECRUITING
Brief Summary
The goal of this post-market clinical follow up Study is to demonstrate the efficacy, safety, acceptability, and quality of life implications of Essilor® Stellest® spectacle lenses in slowing myopia progression in European children and adolescents. Participants will receive Essilor® Stellest® at inclusion visit and will be asked for a full time wear (\>12 hours daily) for 24 months. The primary endpoints are the change in axial length and cycloplegic autorefraction from baseline to 24 months compared to expected change based on axial length and refraction centile positions at baseline.
Frequently Asked Questions
What is Essilor® Stellest® Lenses Multicentre European Study (SLOMES)?
Essilor® Stellest® Lenses Multicentre European Study (SLOMES) is a clinical trial registered under NCT06263946. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06263946?
The current status of NCT06263946 (Essilor® Stellest® Lenses Multicentre European Study (SLOMES)) is: ACTIVE_NOT_RECRUITING.
When did Essilor® Stellest® Lenses Multicentre European Study (SLOMES) start?
Essilor® Stellest® Lenses Multicentre European Study (SLOMES) started on 2024-03-22.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.